🔎 Trials Near Me

Home › Kanser sa Bato (Renal Cell Carcinoma) › Connecticut › New Haven

Pag-aaral pangklinika para sa Kanser sa Bato (Renal Cell Carcinoma) sa New Haven, CT

Isang pag-aaral para sa Kanser sa Bato (Renal Cell Carcinoma) ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa New Haven. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

Nagre-recruitPhase 1
  • NEO-811 Connecticut Site, New Haven
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07300241

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Nagre-recruitPhase 1
  • Yale - New Haven Hospital, New Haven
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06234605

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Nagre-recruitPhase 1
  • Exelixis Clinical Site #62, New Haven
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05176483

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

Nagre-recruitPhase 1/2
  • Local Institution - 0117, New Haven
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07293351

Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial

Nagre-recruitPhase 2
  • Yale University Cancer Center LAO, New Haven
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07516366

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Nagre-recruitPhase 3
  • Yale University, New Haven
  • Smilow Cancer Hospital-Derby Care Center, Derby · 8 mi ang layo
  • Smilow Cancer Hospital Care Center - Guilford, Guilford · 13 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06661720

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Nagre-recruitPhase 1
  • Xencor Investigative Site, New Haven
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT05433142

Investigation of Lymph Node Biology in Kidney Cancer

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
  • Yale University, New Haven
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 16, 2026 · NCT07038733

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Nagre-recruitPhase 1
  • Yale University School of Medicine /ID# 225707, New Haven
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT04777994

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Nagre-recruitPhase 1/2
  • Yale School of Medicine, North Haven · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 28, 2026 · NCT06413680

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

Nagre-recruitPhase 2
  • Yale University, New Haven
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 4, 2025 · NCT04974671

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Nagre-recruitPhase 1/2
  • Yale Cancer Center, New Haven
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 15, 2024 · NCT04787042

Pag-aaral para sa Kanser sa Bato (Renal Cell Carcinoma) sa ibang lungsod

Iba pang pag-aaral sa New Haven

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.